Download PDF
Thromb Haemost 2006; 96(05): 630-641
DOI: 10.1160/TH06-07-0383
Blood Coagulation, Fibrinolysis and Cellular Haemostasis
Schattauer GmbH

An investigation of the von Willebrand factor genotype in UK patients diagnosed to have type 1 von Willebrand disease

Anthony Cumming
1   University Department of Haematology, Manchester Royal Infirmary, Manchester, UK
,
Pamela Grundy
1   University Department of Haematology, Manchester Royal Infirmary, Manchester, UK
,
Stephen Keeney
1   University Department of Haematology, Manchester Royal Infirmary, Manchester, UK
,
William Lester
2   Department of Haematology, Birmingham Children’s Hospital, Birmingham, UK
,
Said Enayat
2   Department of Haematology, Birmingham Children’s Hospital, Birmingham, UK
,
Andrea Guilliatt
2   Department of Haematology, Birmingham Children’s Hospital, Birmingham, UK
,
Derrick Bowen
3   Department of Haematology, University of Wales College of Medicine, Cardiff, UK
,
John Pasi
4   Department of Haematology, Royal London Hospital, London, UK
,
David Keeling
5   Oxford Haemophilia Centre, Churchill Hospital, Oxford, UK
,
Frank Hill
2   Department of Haematology, Birmingham Children’s Hospital, Birmingham, UK
,
Paula H. B. Bolton-Maggs
1   University Department of Haematology, Manchester Royal Infirmary, Manchester, UK
,
Charles Hay
1   University Department of Haematology, Manchester Royal Infirmary, Manchester, UK
,
Peter Collins
3   Department of Haematology, University of Wales College of Medicine, Cardiff, UK
,
on behalf of the UK Haemophilia Centre Doctors’ Organisation › Author AffiliationsFinancial support: This work was supported in part by a grant from the UK Haemophilia Society.
Further Information

Publication History

Received 11 July 2006

Accepted after revision 15 September 2006

Publication Date:
01 December 2017 (online)

Also available at
    Permissions and Reprints

Summary

Forty families diagnosed by UK centres to have type 1 VWD were recruited. Following review, six families were re-diagnosed to have type 2 VWD, one to have a platelet storage pool disorder, and one family was determined to be unaffected. Direct DNA sequencing of the promoter region and all exons and intronic boundaries of the VWF gene identified six mutations likely to be causative of VWD in index cases of nine of the 32 (28%) confirmed type 1 VWD families. These included R1205H (3614G>A) VWD Vicenza, P1648fsX45 (4944delT), D141G (422A>G) and three splice site mutations: 3108+5G>A, 7437+1G>A and 3379+1G>A. The Y1584C (4751A>G) polymorphism was present in eight additional families. No significant VWF gene mutation or polymorphism was identified in 15 of the32 type 1VWD index cases (47%). Haplotype studies were performed using a panel of VWF polymorphisms to investigate the segregation in families of VWD phenotype with the VWF gene. In 13 of the 32 families it was likely that VWD segregated with the VWF gene. In eight families (25%) VWD clearly did not segregate with the VWF gene. We suggest that mutation screening of the VWF gene has limited general utility in genetic diagnostic and family studies in type 1 VWD. If genetic studies are performed, the incomplete penetrance and variable expressivity of type 1 VWD must be taken into account. Unless linkage of VWD phenotype with the VWF gene can be clearly demonstrated, the results of any genetic family studies should be interpreted with caution.

Keywords

Type 1VWD, VWF gene mutations - inherited bleeding disorders - molecular pathogenesis
 

  • References

  • 1 Rodeghiero F. von Willebrand disease: still an intriguing disorder in the era of molecular medicine. Haemophilia 2002; 08: 292-300.
    CrossrefPubMedGoogle Scholar
  • 2 Sadler JE. A revised classification of von Willebrand disease. For the Subcommittee on von Willebrand factor of the Scientific and Standardization Committee of the International Society on Thrombosis and Haemostasis. Thromb Haemost 1994; 71: 520-5.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 3 Rodeghiero F, Castaman G, Dini E. Epidemiological investigation of the prevalence of von Willebrand’s disease. Blood 1987; 69: 454-9.
    PubMedGoogle Scholar
  • 4 Werner EJ, Broxson EH, Tucker EL. et al. Prevalence of von Willebrand disease in children: A multiethnic study. J Pediatr 1993; 123: 893-8.
    CrossrefPubMedGoogle Scholar
  • 5 Nichols WC, Ginsburg D. Reviews in molecular medicine: von Willebrand disease. Medicine 1997; 76: 1-20.
    CrossrefPubMedGoogle Scholar
  • 6 Miller CH, Graham JB, Goldin LR. et al. Genetics of classic von Willebrand’s disease. I. Phenotypic variation within families. Blood 1979; 54: 117-45.
    PubMedGoogle Scholar
  • 7 Castaman G, Eikenboom JCJ, Bertina RM. et al. Inconsistency of association between type 1 von Willebrand disease phenotype and genotype in families identified in an epidemiological investigation. Thromb Haemost 1999; 82: 1065-70.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 8 Casana P, Martinez F, Haya S. et al. Significant linkage and non-linkage of type 1 von Willebrand disease to the von Willebrand factor gene. Br J Haematol 2001; 115: 692-700.
    CrossrefPubMedGoogle Scholar
  • 9 Lanke E, Johansson AM, Hallden C. et al. Genetic analysis of 31 Swedish type 1 von Willebrand disease families reveals incomplete linkage to the von Willebrand factor gene and a high frequency ofa certain disease haplotype. J Thromb Haemost 2005; 03: 2656-63.
    CrossrefPubMedGoogle Scholar
  • 10 Eikenboom J, van Marion V, Putter H. et al. Linkage analysis in families diagnosed with type 1 von Willebrand disease in the European study, molecular and clinical markers for the diagnosis and management of type 1 VWD. J Thromb Haemost 2006; 04: 774-82.
    CrossrefPubMedGoogle Scholar
  • 11 James PD, Paterson AD, Notley C. et al. Genetic linkage and association analysis in type 1 von Willebrand disease: results from the Canadian Type 1 VWD Study. J Thromb Haemost 2006; 04: 783-92.
    CrossrefPubMedGoogle Scholar
  • 12 Sadler JE, Rodeghiero F. on behalf of the ISTHSS Subcommittee on von Willebrand Factor. Provisional criteria for the diagnosis of VWD type 1. J Thromb Haemost 2005; 03: 775-7.
    CrossrefPubMedGoogle Scholar
  • 13 Sadler JE. Von Willebrand disease type 1: a diagnosis in search of a disease. Blood 2003; 101: 2089-93.
    CrossrefPubMedGoogle Scholar
  • 14 Sadler JE. Slippery criteria for von Willebrand disease type 1. J Thromb Haemost 2004; 02: 1720-3.
    CrossrefPubMedGoogle Scholar
  • 15 Levy G, Ginsburg D. Getting at the variable expressivity of von Willebrand disease. Thromb Haemost 2001; 86: 144-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 16 De Lange M, de Geus EJ, Kluft C. et al. Genetic influences on fibrinogen, tissue plasminogen activatorantigen and von Willebrand factor in males and females. Thromb Haemost 2006; 95: 414-9.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 17 Orstavik KH, Magnus P, Reisner H. et al. Factor VIII and factor IX in a twin population. Evidence for a major effect of ABO locus on factor VIII level. Am J Hum Genet 1985; 37: 89-101.
    PubMedGoogle Scholar
  • 18 Gill JC, Endres-Brooks J, Bauer PJ. et al. The effect of ABO blood group on the diagnosis of von Willebrand disease. Blood 1987; 69: 1691-5.
    PubMedGoogle Scholar
  • 19 Keeney S, Cumming AM. The molecular biology of von Willebrand disease. Clin Lab Haem 2001; 23: 209-30.
    CrossrefPubMedGoogle Scholar
  • 20 Laffan M, Brown SA, Collins PW. et al. The diagnosis of von Willebrand disease: a guideline from the UK Haemophilia Centre Doctors’ Organisation. Haemophilia 2004; 10: 199-217.
    CrossrefPubMedGoogle Scholar
  • 21 Federici AB, Canciani MT, Forza I. et al. Ristocetin cofactor and collagen binding activities normalized to antigen levels for a rapid diagnosis of type 2 von Willebrand disease. Single center comparison of four different assays. Thromb Haemost 2000; 84: 1127-8.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 22 Enayat MS, Hill FGH. Analysis of the complexity of the multimeric structure of factor VIII-related antigen/von Willebrand protein using a modified electrophoretic technique. J Clin Pathol 1983; 36: 915-9.
    CrossrefPubMedGoogle Scholar
  • 23 Mancuso DJ, Tuley EA, Westfield LA. et al. Structure of the gene for human von Willebrand factor. J Biol Chem 1989; 264: 19514-27.
    PubMedGoogle Scholar
  • 24 Strauss EC, Kobori JA, Siu G. et al. Specificprimer-directed DNA sequencing. Anal Biochem 1986; 154: 353-60.
    CrossrefPubMedGoogle Scholar
  • 25 Bonfield JK, Rada C, Staden R. Automated detection of point mutations using fluorescent sequence trace subtraction. Nucleic Acids Res 1998; 26: 3404-9.
    CrossrefPubMedGoogle Scholar
  • 26 Hilbert L, Gaucher C, Mazurier C. Identification of two mutations (Arg611Cys and Arg611His) in the A1 loop of von Willebrand factor (vWF) responsible for type 2 von Willebrand disease with decreased plateletdependent function of vWF. Blood 1995; 86: 1010-8.
    PubMedGoogle Scholar
  • 27 Castaman G, Eikenboom JCJ, Rodeghiero F. et al. A novel candidate mutation (Arg611→His) in type I “platelet discordant” von Willebrand’s disease with desmopressin-induced thrombocytopenia. Br J Haematol 1995; 89: 656-8.
    CrossrefPubMedGoogle Scholar
  • 28 Castaman G, Rodeghiero F, Mannucci PM. The elusive pathogenesis of von Willebrand disease Vicenza. Blood 2002; 99: 4243-4.
    CrossrefPubMedGoogle Scholar
  • 29 Castaman G, Missiaglia E, Federici AB. et al. An additional unique candidate mutation (G2470A; M740I) in the original families with von Willebrand disease type 2M Vicenza and the G3864A (R1205H) mutation. Thromb Haemost 2000; 84: 350-1.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 30 Schneppenheim R, Federici AB, Budde U. et al. Von Willebrand disease type 2M “Vicenza” in Italian and German patients: identification of the first candidate mutation (G3864A; R1205H) in 8 families. Thromb Haemost 2000; 82: 136-40.
    Article in Thieme ConnectPubMedGoogle Scholar
  • 31 Baronciani L, Cozzi G, Canciani MT. et al. Molecular defects in type 3 von Willebrand disease: updated results from 40 multiethnic patients. Blood Cells Mol Dis 2003; 30: 264-70.
    CrossrefPubMedGoogle Scholar
  • 32 Bowen DJ, Collins PW, Lester W. et al. The prevalence of the cysteine1584 variant of von Willebrand factor is increased in type 1 von Willebrand disease: cosegregation with increased susceptibility to ADAMTS13 proteolysis but not clinical phenotype. Br J Haematol 2005; 128: 830-6.
    CrossrefPubMedGoogle Scholar
  • 33 Bowen DJ, Collins PW. An amino acid polymorphism in von Willebrand factor correlates with increased susceptibility to proteolysis by ADAMTS13. Blood 2004; 103: 941-7.
    PubMedGoogle Scholar
  • 34 Bowen DJ. An influence of ABO blood group on the rate of proteolysis of von Willebrand factor by ADAMTS13. J Thromb Haemost 2003; 01: 33-40.
    CrossrefPubMedGoogle Scholar
  • 35 O’Brien LA, James PD, Othman M. et al. Founder von Willebrand factor haplotype associated with type 1 von Willebrand disease. Blood 2003; 102: 549-57.
    CrossrefPubMedGoogle Scholar
  • 36 Hilbert L, Jorieux S, Proulle V. et al. Two novel mutations, Q1053H and C1060R, located in the D3 domain of von Willebrand factor, are responsible for decreased FVIII-binding capacity. Br J Haematol 2003; 120: 627-32.
    CrossrefPubMedGoogle Scholar
  • 37 Berber E, James PD, Leggo J. et al. Effect of the R924Q von Willebrand factor substitution on the expression of the von Willebrand disease phenotype. Blood. 2003 102. Abstract 307.
    PubMedGoogle Scholar
  • 38 Padgett RA, Grabowski PJ, Konarska MM. et al. Splicing of messenger RNA precursors. Annu Rev Biochem 1986; 55: 1119-50.
    CrossrefPubMedGoogle Scholar
  • 39 Bódo I, Katsumi A, Tuley EA. et al. Type 1 von Willebrand disease mutation Cys1149Arg causes intracellular retention and degradation of heterodimers: a possible general mechanism for dominant mutations of oligomeric proteins. Blood 2001; 98: 2973-9.
    CrossrefPubMedGoogle Scholar
  • 40 James PD, Notley C, Hegadorn C. et al. The mutational spectrum of type 1 von Willebrand disease: results from a Canadian cohort study. Blood first edition paper, prepublished online. August 10 2006 doi:10.1182/blood-2006-05-021105.
    PubMedGoogle Scholar
  • 41 Keightley AM, Lam YM, Brady JN. et al. Variation at the von Willebrand factor (vWF) gene locus is associated with plasma vWF:Ag levels: identification of three novel single nucleotide polymorphisms in the vWF gene promoter. Blood 1999; 93: 4277-83.
    PubMedGoogle Scholar
  • 42 Johansson AM, Säll T, Lethagen S. et al. The haplotype structure of the von Willebrand factor (VWF) gene promoter indicates balancing selection. J Thromb Haemost. 2005 03. (Suppl 1): Abstract P1466.
    PubMedGoogle Scholar
  • 43 Kunicki TJ, Federici AB, Salomon DR. et al. An association of candidate gene haplotypes and bleeding severity in von Willebrand disease (VWD) type 1 pedigrees. Blood 2004; 140: 2359-67.
    PubMedGoogle Scholar
  • 44 Di Paola J, Federici AB, Mannucci PM. et al. Low platelet a2ß1 levels in type 1 von Willebrand disease correlate with impaired platelet function in a high shear stress system. Blood 1999; 93: 3578-82.
    PubMedGoogle Scholar